Clik here to view.
Ophthotech Corporation to Report First Quarter 2017 Financial Results and...
Wednesday, April 26th 2017 at 11:30am UTC NEW YORK–(BUSINESS WIRE)– Ophthotech Corporation (Nasdaq: OPHT) today announced that it will report its first quarter 2017 financial and operating results on...
View ArticleClik here to view.
UCB Selects Medidata Clinical Cloud® to Support Patient-Centric Drug Development
Wednesday, April 26th 2017 at 10:25am UTC Medidata’s Cutting-Edge Technology Platform to Drive Operational Excellence and Patient Value for Global Biopharma NEW YORK–(BUSINESS WIRE)– class= »bwalignl...
View ArticleClik here to view.
CORRECTING and REPLACING Acorda Provides Financial and Pipeline Update for...
Thursday, April 27th 2017 at 11:15am UTC Corporate restructuring implemented to focus on late-stage Parkinson’s programs 2017 combined R&D and SG&A operating expense guidance revised to $330 –...
View ArticleClik here to view.
Rgenix Appoints Chief Medical Officer
Thursday, April 27th 2017 at 11:00am UTC NEW YORK–(BUSINESS WIRE)– Rgenix, Inc., a clinical stage biopharmaceutical company developing first-in-class small molecule and antibody cancer therapeutics,...
View ArticleClik here to view.
Acorda Provides Financial and Pipeline Update for First Quarter 2017
Thursday, April 27th 2017 at 10:00am UTC Corporate restructuring implemented to focus on late-stage Parkinson’s programs 2017 combined R&D and SG&A operating expense guidance revised to $330 –...
View ArticleClik here to view.
Bristol-Myers Squibb to Take Part in Deutsche Bank Annual Health Care Conference
Thursday, April 27th 2017 at 12:00pm UTC NEW YORK–(BUSINESS WIRE)– Bristol-Myers Squibb Company (NYSE:BMY) will take part in the 42nd Annual Deutsche Bank Health Care Conference on Thursday, May 4,...
View ArticleClik here to view.
Pfizer’s Next-Generation ALK/ROS1 Inhibitor, Lorlatinib, Granted Breakthrough...
Thursday, April 27th 2017 at 12:00pm UTC NEW YORK–(BUSINESS WIRE)– Pfizer Inc. today announced that its investigational next-generation ALK/ROS1 tyrosine kinase inhibitor, lorlatinib, was granted...
View ArticleClik here to view.
Bristol-Myers Squibb Reports First Quarter Financial Results
Thursday, April 27th 2017 at 10:59am UTC Increases First Quarter Revenues 12% to $4.9 Billion Posts First Quarter GAAP EPS of $0.94 and Non-GAAP EPS of $0.84 Achieves Key Regulatory Milestones For...
View ArticleClik here to view.
Cellectis CEO Selected as Speaker for 2017 Milken Institute Global Conference
Thursday, April 27th 2017 at 8:30pm UTC Dr. André Choulika to Serve as Panelist for “Humankind vs. Cancer: The Scorecard” NEW YORK–(BUSINESS WIRE)– Regulatory News: Cellectis (Paris:ALCLS)...
View ArticleClik here to view.
Acorda Expands Alexa Skill Offering for Parkinson’s Awareness Month
Friday, April 28th 2017 at 11:00am UTC ARDSLEY, N.Y.–(BUSINESS WIRE)– Acorda Therapeutics, Inc. (Nasdaq:ACOR) today announced the launch of The Many Faces of OFF℠ Facebook Feed, a new skill for the...
View ArticleClik here to view.
Pfizer Hosts Annual Meeting of Shareholders
Thursday, April 27th 2017 at 4:30pm UTC Declares 32-Cent Second-Quarter 2017 Dividend NEW YORK–(BUSINESS WIRE)– The board of directors of Pfizer Inc. today declared a 32-cent second-quarter 2017...
View ArticleClik here to view.
WorldQuant Initiative for Quantitative Prediction Established at Weill...
Friday, April 28th 2017 at 11:59am UTC Initiative Combines State-of-the-Art Molecular Profiling Technologies with Advanced Financial Algorithms and Computational Methods to Enhance Precision Medicine...
View ArticleClik here to view.
Acorda to Present at the Deutsche Bank 42nd Annual Healthcare Conference
Tuesday, May 2nd 2017 at 10:00am UTC ARDSLEY, N.Y.–(BUSINESS WIRE)– Acorda Therapeutics, Inc. (Nasdaq: ACOR) will present at the Deutsche Bank 42nd Annual Healthcare Conference in Boston on Thursday,...
View ArticleClik here to view.
Novocure to Present at Three Upcoming Investor Conferences in May
Monday, May 1st 2017 at 11:30am UTC ST. HELIER, Jersey–(BUSINESS WIRE)– Novocure (NASDAQ:NVCR) announced today that it will participate in three upcoming investor conferences in May. William Doyle,...
View ArticleClik here to view.
Ophthotech Reports First Quarter 2017 Financial and Operating Results
Wednesday, May 3rd 2017 at 11:30am UTC – Conference Call and Webcast Today, May 3, 2017, at 8:00 a.m. ET – NEW YORK–(BUSINESS WIRE)– Ophthotech Corporation (Nasdaq:OPHT) today announced financial and...
View ArticleClik here to view.
FDA Authorizes Clinical Trial for 22nd Century’s BRAND B Low Tar-to-Nicotine...
Monday, May 1st 2017 at 10:55am UTC 22nd Century’s Proprietary Brand B Cigarettes Will be a Modified-Risk-Tobacco-Product Candidate CLARENCE, N.Y.–(BUSINESS WIRE)– 22nd Century Group, Inc. (NYSE MKT:...
View ArticleClik here to view.
Pfizer Announces U.S. FDA Filing Acceptance of Supplemental New Drug...
Wednesday, May 3rd 2017 at 1:00pm UTC NEW YORK–(BUSINESS WIRE)– Pfizer Inc. announced today that the United States Food and Drug Administration (FDA) has accepted for review the supplemental New Drug...
View ArticleClik here to view.
Phase 3 OCTAVE Studies of Oral Tofacitinib in Ulcerative Colitis Results...
Wednesday, May 3rd 2017 at 9:25pm UTC Data Demonstrated Tofacitinib was Effective as Both Induction and Maintenance Therapy in the Treatment of Moderate to Severe Ulcerative Colitis NEW YORK–(BUSINESS...
View ArticleClik here to view.
Acceleron to Participate in Two Healthcare Investor Conferences in May
Monday, May 1st 2017 at 11:00am UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– Acceleron Pharma Inc. (NASDAQ:XLRN), a clinical stage biopharmaceutical company focused on the discovery, development and...
View ArticleClik here to view.
PFIZER REPORTS FIRST-QUARTER 2017 RESULTS
Tuesday, May 2nd 2017 at 10:45am UTC First-Quarter 2017 Revenues of $12.8 Billion, Reflecting 1% Operational Decline, Unfavorably Impacted by One Less U.S. Selling Day and Two Fewer International...
View Article